How do you pay?

How to pay the least

Cash price

$2,730+ for 30 tablets

Pharmacies pay about this for Blujepa; you’d pay more.

  1. Ask your pharmacy for Blujepa’s cash price, and one or two other pharmacies too.
  2. Blujepa’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify GSK Patient Assistance Program (prescription medicines). Or call 1-866-728-4368.

See if you qualify 

No generic is sold yet.

Compare every option

Question
Brand nameBlujepa
Authorized genericgepotidacin
Regular genericgepotidacin
What you’d pay
At least$2,730for 30 tablets; pharmacies pay this
Not soldThere isn’t one
Not soldNone sold yet
Same as Blujepa?
The original
–
–

Brand nameThe maker’s card

BLUJEPA Savings Coupon

Savings card from GSK

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $30 a fill

Sign up on blujepa.com 

See the offer on blujepa.com

In the maker’s words

“TERMS OF USE: Eligible commercially insured/covered patients with no restrictions (step-edit, prior authorization, or NDC block) and with a valid prescription for BLUJEPA (gepotidacin) who present this card at participating pharmacies will pay as little as $30, subject to a maximum limit of wholesale acquisition cost (WAC), less $30 per fill.”

From the maker’s offer on blujepa.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Blujepa itself, from the same company, sold without the brand name, and usually for less. For now Blujepa is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

BLUJEPA is a triazaacenaphthylene bacterial type II topoisomerase inhibitor indicated for the treatment of the following infections caused by susceptible microorganisms:

  • Uncomplicated urinary tract infections (uUTI) in female adult and pediatric patients 12 years of age and older weighing at least 40 kilograms (kg).
  • Uncomplicated urogenital gonorrhea in adult and pediatric patients 12 years of age and older weighing at least 45 kilograms who have limited or no alternative treatment options. Approval of this indication is based on limited clinical safety data for this indication.

Usage to Reduce Development of Drug-Resistant Bacteria

To reduce the development of drug-resistant bacteria and maintain the effectiveness of BLUJEPA and other antibacterial drugs, BLUJEPA should be used only to treat infections that are proven or strongly suspected to be caused by bacteria.

Source: the FDA label for Blujepa (GlaxoSmithKline LLC), February 10, 2026. Full label on DailyMed 

Good to know